Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …

Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Objective The objective of this study was to summarize the literature regarding the effects of
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …

INTRODUCTION: Antiplatelet agents, 3-hydroxy-3-methylglutaryl coenzyme A reductase
inhibitors (statin drugs), angiotensin converting enzyme (ACE) inhibitors, and β-adrenergic …

Background Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and
rupture of aortic aneurysms in animals. We investigated the association between ACE …

Background Abdominal aortic aneurysm (AAA) is a complex degenerative disease, which
leads to morbidity and mortality in a large portion of the elderly population. Current treatment …

Abdominal aortic aneurysm (AAA) is a common and life-threatening disease characterized
by progressive dilatation and rupture, and has a mortality rate of up to 90%. Surgical repair …

Abdominal aortic aneurysm (AAA) causes∼ 170 000 deaths annually worldwide. Most
guidelines recommend asymptomatic small AAAs (30 to< 50 mm in women; 30 to< 55 mm in …

Abdominal aortic aneurysms (AAA) are the most common arterial aneurysms. Endovascular
or open surgical aneurysm repair is indicated in patients with large AAA≥ 5.5 cm in …